Clinical Syringe Packages Increase Productivity

Publication
Article
BioPharm InternationalBioPharm International-05-01-2014
Volume 27
Issue 5

Clinical Syringe Packages Increase Productivity

Vetter introduces two clinical syringe packages that can start syringe development earlier in the drug development process, potentially cutting up to 18 months off time-to-market. Vetter’s Clinical Syringe Standard Package includes all development activities through launch, while the Clinical Syringe Starter Package offers a range of testing without the financial commitment to a clinical fill.

The standard package is an inclusive service, starting with the materials selection, which is a combination of syringe, needle, and stopper to meet a compound’s requirements and continuing through cGMP clinical syringe filling. The starter package begins with the same materials selection, proceeds through feasibility testing and regulatory consultation, and ends with a non-cGMP stability run.

According to the company, these packages may make it easier to recruit medical clinics for trials that use prefilled syringes, since they require less handling and preparation than vials and have reduced risk of needle-sticks.

Vetter

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.